SP-100030 (CAS No 154563-54-9) is a promising compound in the field of biomedical research particularly within cancer biology and neurodegenerative studies Originating from targeted drug discovery efforts it functions primarily through the inhibition of specific cellular pathways contributing to its role as a potential therapeutic agent This compound exhibits potent activity in the nanomolar to low micromolar range demonstrating efficacy across various in vitro assays It is frequently utilized in cellular models including various cancer cell lines and is a candidate in preclinical animal studies aimed at understanding its pharmacokinetics and efficacy Additionally SP-100030 is a valuable tool in drug screening processes to identify novel therapeutic targets Experimental concentrations typically depend on the specific research design ensuring flexibility in various experimental setups